Literature DB >> 21113156

Uncoupling the dopamine D1-D2 receptor complex exerts antidepressant-like effects.

Lin Pei1, Shupeng Li, Min Wang, Mustansir Diwan, Hymie Anisman, Paul J Fletcher, José N Nobrega, Fang Liu.   

Abstract

We report that coupling between dopamine D1 and D2 receptors was markedly increased in postmortem brain of subjects suffering from major depression. Biochemical analyses revealed that D1 and D2 receptors form heterodimers via a direct protein-protein interaction. Administration of an interfering peptide that disrupts the D1-D2 receptor complex substantially reduced immobility in the forced swim test (FST) without affecting locomotor activity, and decreased escape failures in learned helplessness tests in rats.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21113156     DOI: 10.1038/nm.2263

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  20 in total

Review 1.  The role of dopamine in the mechanism of action of antidepressant drugs.

Authors:  P S D'Aquila; M Collu; G L Gessa; G Serra
Journal:  Eur J Pharmacol       Date:  2000-09-29       Impact factor: 4.432

Review 2.  Use of bupropion in combination with serotonin reuptake inhibitors.

Authors:  Sidney Zisook; A John Rush; Barbara R Haight; Dawn C Clines; Carol B Rockett
Journal:  Biol Psychiatry       Date:  2005-09-13       Impact factor: 13.382

3.  Disruption of the dopamine transporter-dopamine D2 receptor interaction in schizophrenia.

Authors:  Frank J S Lee; Lin Pei; Fang Liu
Journal:  Synapse       Date:  2009-08       Impact factor: 2.562

4.  Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.

Authors:  A John Rush; Madhukar H Trivedi; Stephen R Wisniewski; Andrew A Nierenberg; Jonathan W Stewart; Diane Warden; George Niederehe; Michael E Thase; Philip W Lavori; Barry D Lebowitz; Patrick J McGrath; Jerrold F Rosenbaum; Harold A Sackeim; David J Kupfer; James Luther; Maurizio Fava
Journal:  Am J Psychiatry       Date:  2006-11       Impact factor: 18.112

5.  Antidepressant-like effects of dopamine agonists in an animal model of depression.

Authors:  R Muscat; M Papp; P Willner
Journal:  Biol Psychiatry       Date:  1992-05-01       Impact factor: 13.382

6.  Calcium signaling cascade links dopamine D1-D2 receptor heteromer to striatal BDNF production and neuronal growth.

Authors:  Ahmed Hasbi; Theresa Fan; Mohammad Alijaniaram; Tuan Nguyen; Melissa L Perreault; Brian F O'Dowd; Susan R George
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-30       Impact factor: 11.205

Review 7.  Emerging drugs for schizophrenia.

Authors:  Ofer Agid; Shitij Kapur; Gary Remington
Journal:  Expert Opin Emerg Drugs       Date:  2008-09       Impact factor: 4.191

8.  Dopamine D1 and D2 receptor Co-activation generates a novel phospholipase C-mediated calcium signal.

Authors:  Samuel P Lee; Christopher H So; Asim J Rashid; George Varghese; Regina Cheng; A José Lança; Brian F O'Dowd; Susan R George
Journal:  J Biol Chem       Date:  2004-05-24       Impact factor: 5.157

9.  Repeated treatment with imipramine and amitriptyline reduced the immobility of rats in the swimming test by enhancing dopamine mechanisms in the nucleus accumbens.

Authors:  L Cervo; R Samanin
Journal:  J Pharm Pharmacol       Date:  1988-02       Impact factor: 3.765

Review 10.  Dynamics of the dopaminergic system as a key component to the understanding of depression.

Authors:  Gal Yadid; Alexander Friedman
Journal:  Prog Brain Res       Date:  2008       Impact factor: 2.453

View more
  54 in total

Review 1.  Functional selectivity in GPCR heterocomplexes.

Authors:  J González-Maeso; S C Sealfon
Journal:  Mini Rev Med Chem       Date:  2012-08       Impact factor: 3.862

2.  Enhanced brain-derived neurotrophic factor signaling in the nucleus accumbens of juvenile rats.

Authors:  Melissa L Perreault; Theresa Fan; Brian F O'Dowd; Susan R George
Journal:  Dev Neurosci       Date:  2013-09-07       Impact factor: 2.984

Review 3.  Heteromeric dopamine receptor signaling complexes: emerging neurobiology and disease relevance.

Authors:  Melissa L Perreault; Ahmed Hasbi; Brian F O'Dowd; Susan R George
Journal:  Neuropsychopharmacology       Date:  2013-06-18       Impact factor: 7.853

4.  Heteromultimerization of cannabinoid CB(1) receptor and orexin OX(1) receptor generates a unique complex in which both protomers are regulated by orexin A.

Authors:  Richard J Ward; John D Pediani; Graeme Milligan
Journal:  J Biol Chem       Date:  2011-09-09       Impact factor: 5.157

Review 5.  Dopamine receptors - IUPHAR Review 13.

Authors:  Jean-Martin Beaulieu; Stefano Espinoza; Raul R Gainetdinov
Journal:  Br J Pharmacol       Date:  2015-01       Impact factor: 8.739

Review 6.  The prevalence, maintenance, and relevance of G protein-coupled receptor oligomerization.

Authors:  Graeme Milligan
Journal:  Mol Pharmacol       Date:  2013-04-30       Impact factor: 4.436

Review 7.  Disease-specific heteromerization of G-protein-coupled receptors that target drugs of abuse.

Authors:  Ivone Gomes; Wakako Fujita; Moraje V Chandrakala; Lakshmi A Devi
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

8.  The glucocorticoid receptor-FKBP51 complex contributes to fear conditioning and posttraumatic stress disorder.

Authors:  Haiyin Li; Ping Su; Terence Ky Lai; Anlong Jiang; Jing Liu; Dongxu Zhai; Charlie Tg Campbell; Frankie Hf Lee; WeiDong Yong; Suvercha Pasricha; Shupeng Li; Albert Hc Wong; Kerry J Ressler; Fang Liu
Journal:  J Clin Invest       Date:  2020-02-03       Impact factor: 14.808

9.  Detection of Receptor Heteromerization Using In Situ Proximity Ligation Assay.

Authors:  Ivone Gomes; Salvador Sierra; Lakshmi A Devi
Journal:  Curr Protoc Pharmacol       Date:  2016-12-13

10.  Prion Protein Modulates Monoaminergic Systems and Depressive-like Behavior in Mice.

Authors:  Danielle Beckman; Luis E Santos; Tatiana A Americo; Jose H Ledo; Fernando G de Mello; Rafael Linden
Journal:  J Biol Chem       Date:  2015-07-07       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.